Fortunately, immunophenoscore was developed to comprehensively quantify tumor immunogenicity by integrating antigen processing (MHC), checkpoints, immunomodulators, effector cells (activated CD8, activated CD4, Tem CD4, Tem CD8, and suppressor cells (Treg and MDSC). This evidence concerns the gene CD4 and neoplasm.